Product Pathways - PathScan ELISA
PathScan® Phospho-IGF-I Receptor β (Tyr1131) Sandwich ELISA Kit #7302
| Kit Includes | Volume | Solution Color |
|---|---|---|
| Phospho-IGF-I Receptor beta (Tyr1131) Rabbit Antibody Coated Microwells | 96 tests | |
| IGF-I Receptor Mouse Detection Antibody | 11 milliliters | Green |
| Anti-mouse IgG HRP-Linked Antibody | 11 milliliters | Red |
| TMB Substrate | 11 milliliters | Colorless |
| STOP Solution | 11 milliliters | Colorless |
| Sealing Tape | 11 milliliters | |
| 20X Wash Buffer | 25 milliliters | Colorless |
| Sample Diluent | 25 milliliters | Blue |
| Cell Lysis Buffer (10X) # 9803 |
Note: 12 8-well modules –Each module is designed to break apart for 8 tests.
Note: Kit should be stored at 4°C with the exception of Cell Lysis Buffer (10X), which is stored at –20°C (packaged separately).
Species Cross-Reactivity
H
Reactivity Key: H=Human
Description
CST's PathScan® Phospho-IGF-I Receptor beta (Tyr1131) Sandwich ELISA Kit is a solid phase sandwich enzyme-linked immunosorbent assay (ELISA) that detects endogenous levels of IGF-I receptor beta protein when phosphorylated at Tyr1131. A Phospho-IGF-I Receptor beta (Tyr1131) Rabbit Antibody* has been coated onto the microwells. After incubation with cell lysates, phospho-IGF-I Receptor beta is captured by the coated antibody. Following extensive washing, an IGF-I Receptor Mouse Antibody* is added to detect the captured phospho-IGF-I receptor protein. Anti-mouse IgG, HRP-linked Antibody #7076*, is then used to recognize the bound detection antibody. HRP substrate, TMB, is added to develop color. The magnitude of absorbance for this developed color is proportional to the quantity of IGF-I receptor protein phosphorylated at Tyr1131.* Antibodies in kit are custom formulations specific to kit.
Specificity / Sensitivity
CST's PathScan® Phospho-IGF-I Receptor β (Tyr1131) Sandwich ELISA Kit #7302 detects endogenous levels of IGF-I Receptor β protein when phosphorylated at Tyr1131. A significant induction of phosphorylation of IGF-I receptor at Tyr1131 is detected in IGF-I- treated MCF-7 cells using PathScan® Phospho-IGF-I Receptor β (Tyr 1131) Sandwich ELISA Kit #7302 (Figure 1). The levels of total IGF-I receptor β (phospho and nonphospho) shown by Western analysis remain unchanged (Figure 1).
Sandwich ELISA
Figure 1. Treatment of MCF-7 cells with IGF-I stimulates phosphorylation of IGF-I receptor at Tyr1131, detected by PathScan® Phospho-IGF-I Receptor β (Tyr1131) Sandwich ELISA Kit #7302, but does not affect the level of total IGF-I Receptor β protein detected by Western analysis. The absorbance readings at 450 nm are shown in the top figure, while the corresponding Western blots using Phospho-IGF-I Receptor β (Tyr1131)/Insulin Receptor β (Tyr1146) Antibody #3021 (right panel) or IGF-I Receptor β Antibody #3027 (left panel), are shown in the bottom figure.
Sandwich ELISA
Figure 2. The relationship between the protein concentration of untreated and IGF-I-treated MCF-7 cell lysates and the absorbance at 450 nm is shown. Cells were serum starved overnight and then treated with 100 nm IGF-I for 5 min. at 37?C.
Background
Type I insulin-like growth factor receptor (IGF-IR) is a transmembrane receptor tyrosine kinase that is widely expressed in many cell lines and cell types within fetal and postnatal tissues (1-3). Receptor autophosphorylation follows binding of the IGF-I and IGF-II ligands. Three tyrosine residues within the kinase domain (Tyr1131, Tyr1135 and Tyr1136) are the earliest, major autophosphorylation sites (4). Phosphorylation of these three tyrosine residues is necessary for kinase activation (5,6).Insulin receptors (IRs) share significant structural and functional similarity with IGF-I receptors, including the presence of an equivalent tyrosine cluster (Tyr1146/1150/1151) within the kinase domain activation loop. Tyrosine autophosphorylation of insulin receptor is one of the earliest cellular responses to insulin stimulation (7). Autophosphorylation begins with phosphorylation of Tyr1146 and either Tyr1150 or Tyr1151, while full kinase activation requires the triple tyrosine phosphorylation (8).
- Adams, T.E. et al. (2000) Cell. Mol. Life Sci. 57, 1050-1093.
- Baserga, R. et al. (2000) Oncogene 19, 5574-5581.
- Scheidegger, K.J. et al. (2000) J. Biol. Chem. 275, 38921-38928.
- Hernandez-Sanchez, C. et al. (1995) J. Biol. Chem. 270, 29176-29181.
- Lopaczynski, W. et al. (2000) Biochem. Biophys. Res. Commun. 279, 955-960.
- Baserga, R. et al. (1999) Exp. Cell Res. 253, 1-6.
- White, M.F. et al. (1985) J. Biol. Chem. 260, 9470-9478.
- White, M.F. et al. (1988) J. Biol. Chem. 263, 2969-2980.
Application References
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
Companion Products
- 3021 Phospho-IGF-I Receptor β (Tyr1131)/Insulin Receptor β (Tyr1146) Antibody
- 3024 Phospho-IGF-I Receptor β (Tyr1135/1136)/Insulin Receptor β (Tyr1150/1151) (19H7) Rabbit mAb
- 3027 IGF-I Receptor β Antibody
- 3018 IGF-I Receptor β (111A9) Rabbit mAb
- 7076 Anti-mouse IgG, HRP-linked Antibody
- 9803 Cell Lysis Buffer (10X)
